GOENOMICS launched mendle®, a Google-like search tool for biological sequence information, in September 2023. The basis of mendle® is a comprehensive database with the genome annotations of all plants, animals and fungi sequenced to date and in the future. The genome annotations are generated by GOENOMICS' own software. The annotations include protein-coding genes, RNA genes (tRNA, ribosomal RNA, spliceosomal RNA, RNase-P, RNase MRP, telomerase RNA, snoRNA U3) and transposon regions. Currently, mendle® is freely accessible and is in alpha status, i.e. data and figures are constantly being added.
2019 | 1.03 Mio € acquired by Dr. Martin Kollmar through EXIST-Research Transfer Phase I) | |
2021 | Genome annotation prototype | |
2021 | Founding of GOENOMICS GmbH | |
2021 | 1st Place Göttingen County Innovation Award | Category: Startup |
2021 | 2nd Place DurchSTARTer Award of the State of Lower Saxony | Category: Life Science |
2022 | Selected for the Top 50 Startups 2021 | |
2022 | 180 T€ acquired (EXIST-FT Phase II) | |
2022 | Nominated for the Lower Saxony Innovation Award | |
2022 | Funding through the incubators HTI BioIntelligence and HTI GreenTech | |
2023 | Launch of mendle® |
"Thanks to the financial support, we could hire necessary staff and recruit international talent. The flexible budget allocation was a great help. The sales workshop provided valuable insights for our sales strategy, helping us attract potential customers and the HTI’s support in our beta test through its network has been invaluable. HTI BioIntelligence offers a comprehensive program for startups, including tailored webinars and events. Many thanks to the HTI team!"
Christine Kruppa, CFO of Goenomics